Lynne Poole

Overall Survival with Osimertinib in Resected <i>EGFR</i> -Mutated NSCLC

Masahiro Tsuboi, Roy S. Herbst, Thomas John et al. · New England Journal of Medicine · 2023 · 546 citations

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study

Melissa L. Johnson, Byoung Chul Cho, Alexander Luft et al. · Journal of Clinical Oncology · 2022 · 406 citations · Full text

Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study

Rina Hui, Mustafa Özgüroğlu, Augusto Villegas et al. · The Lancet Oncology · 2019 · 185 citations · Full text

Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study

Manfred Döpfner, Hans‐Christoph Steinhausen, David Coghill et al. · European Child & Adolescent Psychiatry · 2006 · 116 citations

Adhd, Neuropsychological Functioning, Psychiatry +11

A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD)

Suyash Prasad, Valerie Harpin, Lynne Poole et al. · Current Medical Research and Opinion · 2007 · 97 citations